Skip to main content

SpectraScience Announces Licensing of Key Technology From Duke University

SAN DIEGO, CA–(Marketwired – May 03, 2016) – SpectraScience, Inc. (OTCQB: SCIE), a medical device company utilizing light technologies to detect and diagnose cancers, announced today that they have concluded a licensing agreement with Duke University. The technology covered is around systems and methods for the use of Angle-Resolved Low Coherence Interferometry in the diagnosis of certain cancers.
http://www.marketwired.com/press-release/spectrascience-announces-licensing-of-key-technology-from-duke-university-otcqb-scie-2120875.htm

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino